BANK OF AMERICA CORP /DE/ - KINIKSA PHARMACEUTICALS LTD ownership

KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 95 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q2 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of KINIKSA PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2023$1,955,150
+50.6%
112,559
+22.0%
0.00%
Q2 2023$1,298,655
-36.1%
92,234
-51.2%
0.00%
Q1 2023$2,033,844
-39.5%
189,019
-15.8%
0.00%
Q4 2022$3,362,201
+244.5%
224,446
+195.5%
0.00%
Q3 2022$976,000
+295.1%
75,948
+197.0%
0.00%
Q2 2022$247,000
-22.6%
25,569
-20.3%
0.00%
Q1 2022$319,000
-79.4%
32,062
-75.6%
0.00%
Q4 2021$1,549,000
+235.3%
131,582
+224.5%
0.00%
Q3 2021$462,000
-2.5%
40,552
+19.2%
0.00%
Q2 2021$474,000
-56.5%
34,020
-42.2%
0.00%
Q1 2021$1,090,000
+135.9%
58,872
+125.1%
0.00%
Q4 2020$462,000
-89.0%
26,152
-90.4%
0.00%
-100.0%
Q3 2020$4,186,000
-36.9%
273,204
+4.8%
0.00%0.0%
Q2 2020$6,639,000
+155.0%
260,581
+54.9%
0.00%
Q1 2020$2,604,000
+51.4%
168,191
+8.2%
0.00%
Q4 2019$1,720,000
+49.2%
155,505
+14.8%
0.00%
Q3 2019$1,153,000
+852.9%
135,512
+1415.3%
0.00%
Q2 2019$121,000
+63.5%
8,943
+118.7%
0.00%
Q1 2019$74,000
-77.4%
4,089
-64.8%
0.00%
Q4 2018$327,000
+1111.1%
11,631
+1021.6%
0.00%
Q3 2018$27,0001,0370.00%
Other shareholders
KINIKSA PHARMACEUTICALS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 2,374,392$36,376,0004.43%
Opaleye Management Inc. 338,000$8,778,0001.72%
Lion Point Capital, LP 495,748$7,594,0001.67%
Fairmount Funds Management LLC 212,746$3,259,0001.38%
Vivo Capital, LLC 1,151,622$17,643,0001.02%
Spearhead Capital Advisors, LLC 270,117$4,138,0000.79%
Integral Health Asset Management, LLC 120,000$1,838,0000.56%
Endurant Capital Management LP 117,480$1,800,0000.53%
SPHERA FUNDS MANAGEMENT LTD. 259,990$3,983,0000.39%
Ikarian Capital, LLC 342,998$5,254,0000.38%
View complete list of KINIKSA PHARMACEUTICALS LTD shareholders